Literature DB >> 27065368

DRCR Protocol-T: Reconciling 1- and 2-Year Data for Managing Diabetic Macular Edema.

Charles C Wykoff, Seenu M Hariprasad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27065368     DOI： 10.3928/23258160-20160324-01

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN： 2325-8160            Impact factor:   1.300


× No keyword cloud information.
  6 in total

1.  Short-term outcomes after the loading phase of intravitreal bevacizumab and subthreshold macular laser in non-center involved diabetic macular edema.

Authors:  Edgar Cuervo-Lozano; Jesús Hernán González-Cortés; Abraham Olvera-Barrios; Ezequiel Treviño-Cavazos; Josué Rodríguez-Pedraza; Karim Mohamed-Noriega; Jesús Mohamed-Hamsho
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

2.  Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema.

Authors:  Sidney A Schechet; Olufemi E Adams; David A Eichenbaum; Seenu M Hariprasad
Journal:  BMJ Open Ophthalmol       Date:  2019-03-29

3.  Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practice.

Authors:  Shinri Sato; Hajime Shinoda; Norihiro Nagai; Misa Suzuki; Atsuro Uchida; Toshihide Kurihara; Mamoru Kamoshita; Yohei Tomita; Chigusa Iyama; Sakiko Minami; Kenya Yuki; Kazuo Tsubota; Yoko Ozawa
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

4.  Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema.

Authors:  Sashwanthi Mohan; Gajendra Chawla; Janani Surya; Rajiv Raman
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 2.969

5.  Intravitreal steroids for macular edema in diabetes.

Authors:  Thanitsara Rittiphairoj; Tahreem A Mir; Tianjing Li; Gianni Virgili
Journal:  Cochrane Database Syst Rev       Date:  2020-11-17

6.  Clinical Characterization of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders.

Authors:  Chen-Rei Wan; Barry Kapik; Charles C Wykoff; Christopher R Henry; Mark R Barakat; Milan Shah; Rafael V Andino; Thomas A Ciulla
Journal:  Transl Vis Sci Technol       Date:  2020-10-22       Impact factor: 3.283
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.